Long-term Performance of Novel Communicating Antitachycardia-Enabled Leadless Pacemaker and Subcutaneous Implantable Cardioverter-Defibrillator System: a Comprehensive Preclinical Study.
Sign Up to like & getrecommendations! Published in 2022 at "Heart rhythm"
DOI: 10.1016/j.hrthm.2022.01.024
Abstract: BACKGROUND Subcutaneous ICDs (S-ICDs) and leadless pacemakers (LPs) are intended to diminish transvenous lead-related complications. However, S-ICDs do not deliver antibradycardia or antitachycardia pacing (ATP) and currently, there is no commercially available coordinated leadless option… read more here.
Keywords: antitachycardia; replacement strategies; system; performance ... See more keywords